FIELD: medicine .
SUBSTANCE: invention refers to medicine and namely to pharmacology and deals with remedies influencing free-radical processes, hemorheology, thrombocyte aggregation and intravascular thrombosis. It has been proposed to use (3,5-dimethyl-4- hydroxy)benzyl thiododecane which is known for its antioxidant activity as antiaggregant remedy decreasing blood hyperviscosity, and antithrombogenic remedy.
EFFECT: there has been shown the stated effectiveness of the remedy by means of blood hyperviscosity pattern and increase of blood flow under conditions of its complete stop when there are no thrombs in arteria the next day.
4 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
| HEMORHEOLOGICAL AND ANTI-THROMBOSIS AGENT | 2003 |
|
RU2242221C1 |
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
| AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
| HEMORHEOLOGICAL AND ANTITHROMBOTIC AGENT | 2003 |
|
RU2239423C1 |
| AGENT AND METHOD FOR CORRECTION OF BONE STRUCTURE DISORDERS CAUSED BY PROLONGED CONSUMPTION OF GLUCOCORTICOIDS | 2018 |
|
RU2710599C2 |
| AGENTS EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2010 |
|
RU2425683C1 |
| AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
| AGENT ELICITING ANTIAGGREGATIVE AND HEMORHEOLOGICAL ACTIVITY | 2001 |
|
RU2180848C1 |
